Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

Clinical trial NCT00466466 · COMPLETED

Trial details

NCT number: NCT00466466
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Small-Cell Lung Cancer

Start date: 2007-04-01
Primary completion: 2010-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.